No Data
No Data
Ultragenyx Pharma Price Target Raised to $111.00/Share From $109.00 by Canaccord Genuity
Ultragenyx Pharma Price Target Raised to $111.00/Share From $109.00 by Canaccord Genuity
Cantor Fitzgerald Adjusts Price Target on Ultragenyx Pharmaceutical to $115 From $107, Maintains Overweight Rating
Ultragenyx Pharmaceutical (RARE) has an average buy rating and a price target range of $47 to $140, according to analysts polled by Capital IQ. Price: 39.81, Change: +1.16, Percent Change: +2.99
Peeling Back The Layers: Exploring Ultragenyx Pharmaceutical Through Analyst Insights
In the last three months, 11 analysts have published ratings on Ultragenyx Pharmaceutical (NASDAQ:RARE), offering a diverse range of perspectives from bullish to bearish.The table below offers a conde
Express News | Ultragenyx Pharmaceutical Inc : BofA Global Research Cuts Price Objective to $76 From $83
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Ultragenyx Pharmaceutical (RARE)
Ultragenyx Pharma Is Maintained at Outperform by Baird
Ultragenyx Pharma Is Maintained at Outperform by Baird